Published in J Mol Biol on October 16, 2007
High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate. Bioorg Med Chem (2008) 1.03
MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity. J Biol Chem (2008) 0.97
Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol (2015) 0.93
NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices. J Biol Chem (2010) 0.92
Ambidextrous binding of cell and membrane bilayers by soluble matrix metalloproteinase-12. Nat Commun (2014) 0.85
Remote exosites of the catalytic domain of matrix metalloproteinase-12 enhance elastin degradation. Biochemistry (2011) 0.84
Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3. Biophys J (2010) 0.83
Molecular determinants of matrix metalloproteinase-12 covalent modification by a photoaffinity probe: insights into activity-based probe development and conformational variability of matrix metalloproteinases. J Biol Chem (2008) 0.81
Path to Collagenolysis: COLLAGEN V TRIPLE-HELIX MODEL BOUND PRODUCTIVELY AND IN ENCOUNTERS BY MATRIX METALLOPROTEINASE-12. J Biol Chem (2016) 0.75
Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor. J Biomol NMR (2008) 0.75
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
The energy landscapes and motions of proteins. Science (1991) 18.93
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
Recognition of errors in three-dimensional structures of proteins. Proteins (1993) 9.38
An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol (1996) 9.31
Evolutionarily conserved pathways of energetic connectivity in protein families. Science (1999) 9.12
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19
The dynamic energy landscape of dihydrofolate reductase catalysis. Science (2006) 7.55
Intrinsic dynamics of an enzyme underlies catalysis. Nature (2005) 7.32
VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol (1997) 6.71
Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat Struct Biol (2003) 6.50
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer (2006) 5.58
CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Res (2003) 4.93
Helix capping. Protein Sci (1998) 4.18
Evolutionary predictions of binding surfaces and interactions. Curr Opin Struct Biol (2002) 3.43
A family of evolution-entropy hybrid methods for ranking protein residues by importance. J Mol Biol (2004) 3.00
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1995) 3.00
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med (2003) 2.64
Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem (1993) 2.56
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Binding sites in Escherichia coli dihydrofolate reductase communicate by modulating the conformational ensemble. Proc Natl Acad Sci U S A (2000) 2.47
Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 2.43
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A (2005) 2.19
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
The structural distribution of cooperative interactions in proteins: analysis of the native state ensemble. Proc Natl Acad Sci U S A (1998) 1.93
Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation (2006) 1.89
Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J Biol Chem (2003) 1.65
Conformational variability of matrix metalloproteinases: beyond a single 3D structure. Proc Natl Acad Sci U S A (2005) 1.65
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem (1996) 1.53
NMR structure of HMfB from the hyperthermophile, Methanothermus fervidus, confirms that this archaeal protein is a histone. J Mol Biol (1996) 1.44
Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol (1999) 1.40
Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett (1988) 1.39
Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun (1996) 1.38
Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol (1998) 1.38
Identification of functional surfaces of the zinc binding domains of intracellular receptors. J Mol Biol (1997) 1.36
Development of selective inhibitors and substrate of matrix metalloproteinase-12. J Biol Chem (2006) 1.30
Evolutionary trace report_maker: a new type of service for comparative analysis of proteins. Bioinformatics (2006) 1.30
Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am J Respir Cell Mol Biol (2000) 1.28
Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am J Pathol (1998) 1.27
Functional residues serve a dominant role in mediating the cooperativity of the protein ensemble. Proc Natl Acad Sci U S A (2007) 1.22
Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem (1995) 1.20
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther (2007) 1.19
Evolutionarily conserved Galphabetagamma binding surfaces support a model of the G protein-receptor complex. Proc Natl Acad Sci U S A (1996) 1.18
Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am J Pathol (2004) 1.16
Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Biochimie (2005) 1.15
Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem Biophys Res Commun (1994) 1.15
Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J Biol Chem (1988) 1.14
1H, 13C, and 15N assignments of MMP-12, a key protease implicated in lung tissue remodeling. J Biomol NMR (2005) 1.13
Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry (1994) 1.13
Snapshots of the reaction mechanism of matrix metalloproteinases. Angew Chem Int Ed Engl (2006) 1.11
Hsc70 contacts helix III of the J domain from polyomavirus T antigens: addressing a dilemma in the chaperone hypothesis of how they release E2F from pRb. Biochemistry (2006) 1.09
Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb Haemost (1999) 1.09
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol (2001) 1.08
Site-directed mutagenesis of the active site glutamate in human matrilysin: investigation of its role in catalysis. Biochemistry (1997) 1.03
Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorg Med Chem Lett (2005) 1.00
Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. J Mol Biol (2004) 1.00
Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry (1994) 0.98
Large-scale expression, refolding, and purification of the catalytic domain of human macrophage metalloelastase (MMP-12) in Escherichia coli. Protein Expr Purif (2000) 0.98
Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. J Mol Biol (2001) 0.94
Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes. J Mol Biol (1999) 0.94
Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis Rheum (2004) 0.93
Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J Biol Chem (1994) 0.92
Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase. J Biomol NMR (1997) 0.91
High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR. Biochemistry (1998) 0.89
Characterizing semilocal motions in proteins by NMR relaxation studies. Proc Natl Acad Sci U S A (1998) 0.87
Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases. J Am Chem Soc (2007) 0.86
Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments. Biochemistry (1993) 0.86
Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1. Protein Eng (2000) 0.84
TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe. Biochemistry (1998) 0.84
1H, 13C, and 15N peak assignments and secondary structure of human macrophage metalloelastase (MMP-12) in its inhibitor-free state. J Biomol NMR (2006) 0.78
Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors. Bioorg Med Chem (2006) 0.77
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases. Arch Biochem Biophys (2003) 0.77
NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Biochemistry (1999) 0.77
Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme. Proc Natl Acad Sci U S A (2005) 2.31
Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3. J Mol Biol (2003) 1.28
Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect. Anal Biochem (2007) 1.17
Mechanistic insights into phosphoprotein-binding FHA domains. Acc Chem Res (2008) 1.15
Hsc70 contacts helix III of the J domain from polyomavirus T antigens: addressing a dilemma in the chaperone hypothesis of how they release E2F from pRb. Biochemistry (2006) 1.09
MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity. J Biol Chem (2008) 0.97
Phosphoprotein and phosphopeptide interactions with the FHA domain from Arabidopsis kinase-associated protein phosphatase. Biochemistry (2007) 0.95
Structural basis for a lethal mutation in U6 RNA. Biochemistry (2003) 0.95
Eukaryotic cyclophilin as a molecular switch for effector activation. Mol Microbiol (2006) 0.94
NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices. J Biol Chem (2010) 0.92
NMR structure of the forkhead-associated domain from the Arabidopsis receptor kinase-associated protein phosphatase. Proc Natl Acad Sci U S A (2003) 0.91
Structure of the UGAGAU hexaloop that braces Bacillus RNase P for action. Nat Struct Biol (2002) 0.90
Solution NMR of a 463-residue phosphohexomutase: domain 4 mobility, substates, and phosphoryl transfer defect. Biochemistry (2012) 0.89
Hsc70-interacting HPD loop of the J domain of polyomavirus T antigens fluctuates in ps to ns and micros to ms. J Mol Biol (2002) 0.88
Partially unfolded forms and non-two-state folding of a beta-sandwich: FHA domain from Arabidopsis receptor kinase-associated protein phosphatase. J Mol Biol (2006) 0.85
Remote exosites of the catalytic domain of matrix metalloproteinase-12 enhance elastin degradation. Biochemistry (2011) 0.84
Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings. Biochemistry (2003) 0.84
Breaking the covalent connection: Chain connectivity and the catalytic reaction of PMM/PGM. Protein Sci (2010) 0.83
Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3. Biophys J (2010) 0.83
PhosphoThr peptide binding globally rigidifies much of the FHA domain from Arabidopsis receptor kinase-associated protein phosphatase. Biochemistry (2005) 0.83
Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria. Biopolymers (2008) 0.82
Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery. ACS Chem Biol (2014) 0.80
The role of collagen charge clusters in the modulation of matrix metalloproteinase activity. J Biol Chem (2013) 0.79
1H, 13C and 15N resonance assignments of the kinase-interacting FHA domain of Arabidopsis thaliana kinase-associated protein phosphatase. J Biomol NMR (2003) 0.79
An examination of the proteolytic activity for bovine pregnancy-associated glycoproteins 2 and 12. Biol Chem (2010) 0.78
Solubilized elastin substrate for continuous fluorimetric assay of kinetics of elastases. Anal Biochem (2010) 0.77
Chemical shift assignments of domain 4 from the phosphohexomutase from Pseudomonas aeruginosa suggest that freeing perturbs its coevolved domain interface. Biomol NMR Assign (2013) 0.77
Metal-mediated targeting in the body. Chem Biol Drug Des (2013) 0.75